These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Hermida RC, Ayala DE, Mojón A, Fernández JR. Chronobiol Int; 2010 Sep; 27(8):1629-51. PubMed ID: 20854139 [Abstract] [Full Text] [Related]
7. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F. Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006 [Abstract] [Full Text] [Related]
8. Treatment of non-dipper hypertension with bedtime administration of valsartan. Hermida RC, Calvo C, Ayala DE, Fernández JR, Covelo M, Mojón A, López JE. J Hypertens; 2005 Oct; 23(10):1913-22. PubMed ID: 16148616 [Abstract] [Full Text] [Related]
9. Decrease in urinary albumin excretion associated with the normalization of nocturnal blood pressure in hypertensive subjects. Hermida RC, Calvo C, Ayala DE, López JE. Hypertension; 2005 Oct; 46(4):960-8. PubMed ID: 16144987 [Abstract] [Full Text] [Related]
13. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial. Hermida RC, Ayala DE, Khder Y, Calvo C. Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247 [Abstract] [Full Text] [Related]
14. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I. Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820 [Abstract] [Full Text] [Related]
15. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study. Lacourcière Y, Wright JT, Samuel R, Zappe D, Purkayastha D, Black HR, EVALUATE study. Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192 [Abstract] [Full Text] [Related]
16. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients. Hermida RC, Ayala DE, Crespo JJ, Mojón A, Chayán L, Fontao MJ, Fernández JR. Chronobiol Int; 2013 Mar; 30(1-2):176-91. PubMed ID: 23077974 [Abstract] [Full Text] [Related]
18. Effects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patients. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M. J Hum Hypertens; 2006 Oct; 20(10):787-94. PubMed ID: 16810279 [Abstract] [Full Text] [Related]
19. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults. Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A. Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047 [Abstract] [Full Text] [Related]
20. Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes. Moyá A, Crespo JJ, Ayala DE, Ríos MT, Pousa L, Callejas PA, Salgado JL, Mojón A, Fernández JR, Hermida RC, Hygia Project Investigators. Chronobiol Int; 2013 Mar; 30(1-2):116-31. PubMed ID: 23181613 [Abstract] [Full Text] [Related] Page: [Next] [New Search]